Abaloparatide OverviewAbaloparatide (brand name Tymlos; formerly BA058) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent. On 28 April 2017, it was approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis. Contents 1 Therapeutics 1.1 Medical use 1.2 Dosage 1.3 Warnings and Precautions 1.4 Side Effects 2 Pharmaco...
Read more Abaloparatide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abaloparatide
Recent Abaloparatide Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 3.12mg/1.56ml (2mg/ml)